Rebecca Kristeleit,BSc, MBChB, MRCP, PhD, was appointed Clinical Senior Lecturer and Consultant Medical Oncologist at UCL/UCLH in 2009. She has a specialist interest in cancer drug development as well as treatment of gynaecological malignancies and is leading a number of clinical trials.

Dr Kristeleit qualified in medicine from St Andrew’s and Manchester Universities including eight months at the University of Lausanne (Switzerland) on an Erasmus scholarship. Following general medical training in London, Dr Kristeleit undertook her specialist training in medical oncology at The Royal Marsden Hospital and a CRUK-funded research fellowship at the Institute of Cancer Research.

Subsequently, Dr Kristeleit spent a year as a senior research fellow on the Drug Development Unit at the Royal Marsden Hospital gaining specialist experience in the design and conduct of early phase cancer clinical trials and translational medicine.

Her research work as part of the core UCLH gynaecological oncology team, UCL/UCLH Clinical Research Facility and UCL Cancer Institute, is focused on the development of innovative early phase trials and translational research studies to identify and evaluate treatment strategies for gynaecologic malignancies as well as other solid tumours.
Dr Kristeleit is a member of the NCRI endometrial cancer sub-group. She has received grant-funding from CRUK and ECMC.
She teaches undergraduate and postgraduate UCL students and supervises students undertaking higher research degrees.